Inhibitory Antibodies
-
F1086 Anti-IgE (M1 prime) Antibody (Quilizumab)Summary: Anti-IgE (M1 prime) Antibody (Quilizumab) -
F1087 Anti-BAFF & IL-17A Antibody (Tibulizumab)Summary: Anti-BAFF & IL-17A Antibody (Tibulizumab) -
F1088 Anti-CanAg Antibody (Cantuzumab mertansine)Summary: Anti-CanAg Antibody (Cantuzumab mertansine) -
F1089 Anti-CEACAM5/CEA/CD66e Antibody (Tusamitamab ravtansine)Summary: Anti-CEACAM5/CEA/CD66e Antibody (Tusamitamab ravtansine) -
F1090 Anti-CanAg Antibody (Cantuzumab ravtansine)Summary: Anti-CanAg Antibody (Cantuzumab ravtansine) -
F1091 Anti-GPNMB Antibody (Glembatumumab vedotin)Summary: Anti-GPNMB Antibody (Glembatumumab vedotin) -
F1092 Anti-FOLR1/FRA Antibody (Mirvetuximab)Summary: Anti-FOLR1/FRA Antibody (Mirvetuximab) -
F1093 Anti-Tau Antibody (Zagotenemab)Summary: Anti-Tau Antibody (Zagotenemab) -
F1094 Anti-NKG2A/CD94 Antibody (Monalizumab)Summary: Anti-NKG2A/CD94 Antibody (Monalizumab) -
F1095 Anti-MUC1 Antibody (Cantuzumab)Summary: Anti-MUC1 Antibody (Cantuzumab)